Elshal Ahmed M, Mekkawy Ramy, Laymon Mahmoud, El-Assmy Ahmed, El-Nahas Ahmed R
Urology and Nephrology Center, Mansoura University, Mansoura, Dakahlia Governorate, Egypt.
Can Urol Assoc J. 2015 Sep-Oct;9(9-10):E618-25. doi: 10.5489/cuaj.3035. Epub 2015 Sep 9.
We assess different approaches to retrieve the enucleated adenoma after transurethral enucleation of the prostate, particularly using the holmium laser.
A retrospective review through our prospectively maintained database was performed looking for safety and efficacy of two morcellators. The enucleation phase of the holmium laser enucleation of the prostate (HoLEP) was classically performed followed by retrieval of the intravesical adenoma using either the Piranha (Wolf Inc., Knittlingen, Germany) or VersaCut (Lumenis) morcellator. A PubMed-MEDLINE search was conducted for all transurethral enucleation procedures and relevant data regarding methods of prostate tissue retrieval were extracted.
Strictly limiting the study to 3 reusable blades with each morcellator, we performed 67 and 55 consecutive procedures with Piranha and VersaCut, respectively. There was no significant difference between the two morcellators regarding perioperative complications, apart from 5 bladder mucosal injuries with the VersaCut (9%). Furthermore, there were similar retrieved tissue weight, mechanical problems-rate, catheter-time and hospital-stay in both morcellators. However, the Piranha morcellator needed significantly less morcellation-time, needed to use cold loop to remove non-morcellated pieces and to score the adenoma by laser for better bite of the adenoma, and had a higher median morcellation-rate 6.2 (rate: 2.8-12) g/min. Despite little reporting on morcellation, we had data on the tissue retrieval rate (2.6 to 6.5 g/min with Piranha and 1.9 to 11 g/min with VersaCut. Furthermore, bladder mucosal injury was reported in 1.4% and 0.7 to 5.7% with Piranha and VersaCut, respectively; bladder perforation with VersaCut was experienced in about 0.1 to 1.5% of patients. Our study is limited by its non-randomization.
The Piranha morcellator was the most efficient and safe way to retrieve tissue after a transurethral enucleation of a prostate adenoma.
我们评估了经尿道前列腺剜除术后取出剜除腺瘤的不同方法,尤其是使用钬激光的方法。
通过我们前瞻性维护的数据库进行回顾性研究,以寻找两种组织粉碎器的安全性和有效性。经典地进行钬激光前列腺剜除术(HoLEP)的剜除阶段,然后使用Piranha(德国克尼特林根的Wolf公司)或VersaCut(科医人公司)组织粉碎器取出膀胱内腺瘤。对所有经尿道剜除术进行PubMed-MEDLINE检索,并提取有关前列腺组织取出方法的相关数据。
严格将研究限制为每个组织粉碎器使用3个可重复使用的刀片,我们分别使用Piranha和VersaCut连续进行了67例和55例手术。除了VersaCut导致5例膀胱黏膜损伤(9%)外,两种组织粉碎器在围手术期并发症方面没有显著差异。此外,两种组织粉碎器的取出组织重量、机械故障率、导尿管留置时间和住院时间相似。然而,Piranha组织粉碎器所需的粉碎时间明显更短,需要使用冷圈套器去除未粉碎的碎片,并通过激光对腺瘤进行标记以更好地咬取腺瘤,并且具有更高的中位粉碎率6.2(范围:2.8 - 12)克/分钟。尽管关于粉碎的报道很少,但我们有组织取出率的数据(Piranha为2.6至6.5克/分钟,VersaCut为1.9至11克/分钟)。此外,Piranha和VersaCut分别有1.4%和0.7%至5.7%的膀胱黏膜损伤报告;约0.1%至1.5%的患者发生了VersaCut导致的膀胱穿孔。我们的研究受到非随机化的限制。
Piranha组织粉碎器是经尿道前列腺腺瘤剜除术后取出组织最有效且安全的方法。